A fast screening method for the detection of more than 60 stimulants in urine was developed. The method consisted of a dilution of the urine (1:5 v/v) and analysis by ultraperformance liquid chromatography coupled to tandem mass spectrometry, using a C18 column (1.7 μm particle size), a mobile phase containing deionized water and acetonitrile with formic acid, and gradient elution. The chromatographic run time was 5 min. The detection was performed in positive mode electrospray ionization, monitoring one or two specific ion transitions for each analyte. Appropriate repeatability was obtained, with relative standard deviation (RSD) values below 25% for most of the analytes. Regarding intermediate precision, estimated during routine work, higher RSDs were obtained, probably due to between day differences in the status of the mass spectrometer and in the chromatographic system. Matrix effect ranged from 60 to 255% with RSD lower than 35% for the majority of compounds. Despite the matrix effect observed, the signal/noise ratio of the analytes spiked at 50 ng/mL was greater than three in all tested samples, allowing a correct detection of all substances at the MRPL required by WADA and demonstrating the suitability of the method. The method was tested in administration study samples and satisfactorily in operation for more than one year with routine doping samples.
INTRODUCTION
The list of prohibited substances and methods of the World Antidoping Agency (WADA) includes more than two hundred pharmacologically and chemically different substances and prohibited methods [1] . Doping control laboratories need to monitor the prohibited substances and/or their metabolites mainly in urine samples. In case of positive results during the initial testing procedure (screening), laboratories apply a second analysis for confirmation purposes.
Screening and confirmation analyses have to be performed in a short period of time according to the International Standard for Laboratories [2] , specially important during major sports events where 24 h reporting times are needed.
Therefore, laboratories are forced to develop high throughput screening and confirmation methods. The use of fast methods has been also a demand in clinical testing for a long time; diagnostic is facilitated by fast analysis, which is important in some emergency cases.
Doping control laboratories use multi-analyte methods to screen for groups of prohibited substances [3] . For long time, screening and confirmation methods were based on gas chromatography coupled to mass spectrometry (GC-MS) [4] .
However, at present, liquid chromatography coupled to mass spectrometry (LC-MS) is currently the technique of choice for the screening and confirmation of most of the groups of substances of doping interest [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] . Different strategies have been described in order to reduce the complexity of the doping control analyses and the total analysis time. LC-MS, either tandem MS or high resolution MS, allow the comprehensive screening of different groups of substances with a simple sample preparation without the need of specific derivatizations as it was needed for GC-MS based methods [4] . In recent years, the availability of robust, sensitive and reliable MS detectors allows the development of methods where sample preparation and/or purification steps are not needed (direct injection or "dilute and shoot" methods) [18, 19, 22, [24] [25] [26] . The direct analysis of conjugated metabolites by LC-MS has also been described to avoid the hydrolysis step during sample preparation [27] . "Dilute and shoot" methods are also especially interesting for compounds with high volatility (e.g. some compounds of the group of stimulants) that may be lost during the evaporation step of the organic solvent used in liquid-liquid or solid-phase extractions [28] .
Another strategy to reduce the analysis time is the use of ultraperformance liquid chromatography (UHPLC) that enables the work with columns packed with small particles (< 2µm). UHPLC is able to produced high resolution by using high linear velocities which results in a reduction of the analysis time.
Methods using UHPLC coupled to tandem MS or to high resolution MS have already been described for the screening and confirmation of some doping agents [15, [18] [19] [20] 23, 26] , demonstrating the reliability of that approach for screening purposes.
Stimulants are a group of substances nowadays frequently analyzed in doping control and analytical toxicology by "dilute and shoot" techniques [18, 19, 22, 24] . They contain an easily-ionizable nitrogen atom and, therefore, the ionization efficiency using electrospray ionization is high. Moreover, although they are metabolized, most of them are excreted in urine in unchanged form in considerable amounts and the detection level required is high [29] . All these factors make "dilute-andshoot" techniques a good choice for screening analysis of stimulants.
The objective of the work was to develop a fast method to screen for stimulants.
A "dilute and shoot" method able to detect more than 60 stimulants by UHPLC-MS/MS is described. Due to isomeric nature of most stimulants, the possibilities for unequivocal identification of the sets of various isomers are also presented. All other solvents and reagents were of analytical grade. Ultrapure water was obteined using a Milli-Q purification system (Millipore Ibérica, Barcelona, Spain).
EXPERIMENTAL

Chemicals and reagents
Standard solutions
Stock standard solutions of 1 mg/mL of the compounds in study were prepared in methanol. Working solutions of 100 and 10 µg/mL were prepared as 1:10 and 1:100 dilutions of the stock solution. All solutions were stored at −20 ºC.
Sample preparation procedures
Preparation for LC-MS/MS
Urine sample (0.5 mL) was centrifuged at 3500 rpm for 5 min. An aliquot of 300 µL was transfered to vial and diluted 1:5 with a mixture of ultrapure water:acetonitrile (99:1, v/v) containing formic acid (1%) and diphenylamine (1 μg/mL) as internal standard (ISTD).
Preparation for GC/MS (underivatized extracts)
A previously described procedure was used [30] . Urine samples (5 mL) were spiked with 25 µL of the ISTD solution (diphenylamine, 1 μg/mL) and were made alkaline with 0.5 mL of 5M KOH. Samples were extracted with tertbutylmethyl eter (2 mL) using salting-out (anhydrous sodium sulphate, 3 g).
After agitation (40 mov/min, 20 min) and centrifugation, the organic phase was evaporated to dryness under nitrogen stream in a water bath at 25ºC. The residue was reconstituted with methanol (100 µL) and analyzed by GC/MS.
Preparation for GC/MS (derivatized extracts)
Samples were extracted as indicated above using MDMA D
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, as ISTD (25 μL of a 100 μg/mL solution). The organic phase was evaporated to dryness, reconstituted with 100 µL of MBTFA and derivatized at 60ºC for 30 min in a dry bath. Extracts were analyzed by GC/MS.
UHPLC-MS/MS instrumental conditions
LC-MS/MS analyses were carried out using a triple quadrupole mass spectrometer (Xevo TQ MS) provided with an orthogonal Z-spray-electrospray interface (ESI) (Waters Associates, Milford, MA, USA) coupled to an ultraperformance liquid chromatographic (UPLC) system (Acquity, Waters
Associates) for the chromatographic separation. Cone gas as well as desolvation gas was nitrogen. The desolvation gas flow was set to approximately 1200 L/h and the cone gas flow to 50 L/h. The nitrogen desolvation temperature was set to 450ºC and the source temperature to 150ºC. Argon was used as collision gas. Electrospray in positive ionization mode was used and the capillary voltages was set at 3.5 kV.
Detection was performed in multiple reaction monitoring mode (MRM). For the separation of isomeric compounds (Groups A-F, Table 3 
GC/MS instrumental conditions
GC/MS analysis were conducted using a 5890 GC gas chromatograph coupled with a 5973 MS mass spectrometer (Agilent Technologies, California, USA). The instrument was equipped with an autosampler 7673 (Agilent Technologies). The capillary column used was a 5% phenylmethyl silicone (12m length, 0.2mm internal diameter, 0.33µm film thickness) (Agilent Technologies). The carrier gas was helium (flow rate 0.9-1.1 mL/min). The injector and the transfer line temperatures were 280°C. The volume of sample injected was 3 µL in split mode (1:10-1:15).
Different temperature programs were applied to achieve the separation of the isomeric compounds:
Ramp 1: initial temperature was kept at 110°C during 14 min, increasing to 280ºC at 20°C/min and held at 280ºC for 4 min.
Ramp 2: initial temperature was set at 90°C, increasing to 300ºC at 20°C/min and held at 300ºC for 4 min.
Ramp 3: initial temperature was set at 90°C, increasing to 290ºC at 20°C/min and held at 290ºC for 5 min.
The analyses were performed in scan mode (m/z 50 to 600 and 40-400) and the characteristic ions for each compounds are listed in Table 3 .
Validation study
The method was validated for qualitative purposes according to a previously described protocol [31] .
Selectivity and specificity were studied by the analysis of 50 different blank urine samples. The absence of any interfering substance at the retention time of the compounds of interest and the internal standard was verified.
The detectability of the analytes was evaluated by analysis of six replicates of blank urine samples spiked with the analytes at 50 ng/mL, corresponding to 50% of the minimum required performance limits (MRPL) defined by WADA [29] .
Intra-assay precision was assessed by analysis of six replicates of blank urine samples spiked at two different concentrations 50 and 100 ng/mL (low and high quality control samples, respectively) on the same day. Intermediate precision was estimated by analysis of one replicate of a quality control sample spiked with a selection of compounds, on six different days. The precision was expressed as the relative standard deviation (RSD) of the ratio between the areas of the compound and the ISTD. The carry over between samples was assessed by analysis of a blank sample just after analysis of a sample spiked with the analytes at high concentration.
Analysis of authentic urine samples
The The method was also applied to routine anti-doping control for a period of one year with analysis of more than 3000 samples
RESULTS AND DISCUSSION
Method development
The compounds studied are nitrogen containing compounds and most of them bear a phenylalkylamine structure ( Table 1 , was the most abundant specie ( Table 1) .
ESI working parameters are listed in Table 1 . In general, low cone voltages and collision energies were used due to the molecular size of the compounds and the stability of the product ions formed. Due to similarities in structures among the compounds of the group, similar fragmentation routes and product ions were also obtained. Different isomeric groups are observed, and they are indicated in Table 1 . The product ion mass spectra of the compounds included in each isomeric group are presented in Figure 1 .
Data acquisition for analysis of urine samples was performed in MRM mode.
For screening purposes, one ion transition was used to monitor most of the compounds. However, for some compounds two ion transitions were measured to increase specificity. A total of 72 ion transitions were measured with time windows of 0.3-0.6 min around the expected retention time of the compound (Table 1 ). The dwell times were automatically adjusted by the instrument software to obtain between 9 and 12 data points per peak, allowing an adequate definition of the chromatographic peaks.
Regarding chromatographic conditions, apart from formic acid, no other mobile phase additives were needed either to promote ionization or to improve chromatographic behavior of the studied compounds. The gradient was optimized to provide a reasonable short chromatographic time allowing for the analysis 63 compounds in only 5 min ( Table 1) . Taking into account the sample preparation used, the chromatographic gradient was optimized to elute polar matrix compounds (e.g. salts) before elution of the analytes in order to avoid problems due to matrix effects. For that reason, the initial percentage of organic solvent was very low, 1%. For the same reason, although not needed for chromatographic separation, the final content of the organic solvent was increased to 90% in order to have a good clean-up of the chromatographic column after each sample analysis.
Due to the high ionization efficiency obtained for the majority of compounds, a simple dilution of the urine was studied as a sample preparation. Due to the complexity of the urine matrix, it is expected that urine dilution results in significant matrix effects produced by urinary interfering compounds that coelute with the analytes and interfere with ionization. A dilution factor of 5 was selected as a compromise between sensitivity and matrix effects. The composition of the solvent used for dilution was optimized to obtain adequate signal intensities and chromatographic peak shapes for all compounds. Splitted peaks were obtained for some analytes due to the pH environment and the fact that the amines are in equilibrium with their respective conjugated acids. In order to avoid them, the diluting solution was acidified to favor one of the species. Trifluoroacetic acid (TFA) and formic acid were evaluated, and results obtained were similar for both modifiers. Taking into account that TFA may produce problems of contamination in the instrument, formic acid was selected.
Different percentages of formic acid in the dilution solvent were studied (0.1%, 1% and 5%). Improvement of peak shape was observed as the percentage of acid increased, especially for some analytes. However, high percentages of acid may also result in contamination problems in the instrument. Therefore, 1%
formic acid was selected as a compromise. Finally, the percentage of organic modifier in the dilution solvent was also studied. A mixture containing the same proportion of water and acetonitrile as the initial composition of the mobile phase (99:1,v/v) was selected, that offered optima signals and peak shapes, especially for some compounds (e.g., p-hydroxy-amphetamine).
Validation of the screening method
The screening method was validated for qualitative purposes for the majority of compounds. A summary of the validation results is presented in Table 2 .
Selectivity and specificity were evaluated by analysis of fifty blank urine samples. The method showed good selectivity and specificity with no interfering peaks. Some interfering peaks were observed close to the expected retention time of some analytes, and two characteristic ion transitions were monitored to improve selectivity in these cases (see Table 1 ). Some isomeric compounds
were not chromatographically separated ( Table 1 , Figure 1 ) and unequivocal identification was not possible in the screening step. The identification of isomeric compounds is described in the specific chapter.
The fulfillment of the WADA criteria regarding the detectability of the analytes was verified by analysis of samples spiked at 50% of the MRPL [29] . For all analytes, a signal/noise ratio greater than 3 was obtained, indicating that the limit of detection is lower than 50 ng/mL for all analytes. . Moreover, the detectability was evaluated using six different urine samples to study the matrix effect. Matrix effect was observed for most of the compounds, either decreasing or increasing the response, and ranged from 60 to 255% with RSD lower than 35% for the majority of compounds, indicating reproducibility between urine samples ( Table 2 ). The presence of matrix effect was expected, taking into consideration the simple sample preparation and the fast chromatographic analysis. It is accepted that the matrix effect in qualitative analysis is less critical mainly for analytes showing high ionization efficiency, as it is the case of stimulants, and the matrix effect is evaluated to ensure that ion suppression does not make the analyte undetectable at the required concentration level in a specific urine [29] . Despite the matrix effect observed in our method, the signal/noise ratio of the analytes spiked at 50 ng/mL was in all samples tested greater than 3, allowing a correct detection of all substances at the MRPL required by WADA and demonstrating the suitability of the method.
Intra-assay precision (n=6) was calculated by analysis of quality control samples at two concentrations levels, 50 and 100 ng/mL ( Carry over between samples was also studied. No signal was observed in blank samples analyzed after samples spiked with high concentrations of the compounds.
As a final validation, administration study samples were analysed. The method was able to detect the administration of amphetamine, benfluorex, clobenzorex, detected. In these regards, the future incorporation of phase II metabolites (glucuronides or sulphates), not limited by the sample preparation step, may considerable improve the detection of some prohibited stimulants [27, 32] In order to evaluate the reliability for routine work, the described method was applied to the analysis of authentic doping control routine samples received in the laboratory for more than one year. In our hands, the system demonstrated to be stable and reliable with simple maintenance operations. Moreover, the method was subjected to the external quality control of WADA for a period of one year with successful results in the identification of positive samples to prolintane, isometheptene, cyclazodone, norpseudoephedrine, ephedrine and pseudoephedrine.
Identification of isomeric stimulants
As mentioned before, there were some isomeric groups including compounds with the same ion transitions and very close retention time in the conditions of the screening analysis ( Table 1) . These isomeric groups are indicated as A, B, C, D, E and F in Table 1 , and their structures and product ion mass spectra can be seen in Figure 1 . Alternative approaches have to be used for identification of a presumptive analytical finding. The procedures available to identify isomeric compounds are listed in Table 3 .
The first possibility is the reanalysis of the samples using LC specific gradient for the separation of each isomeric group, and specific MS/MS methods including characteristic ion transitions ( Table 3) . In this study, compounds within all isomeric groups were separated using improved chromatographic gradients, and the separations achieved are shown in Figure 3 . As an example, for the identification of dimethylamphetamine, ethylamphetamine and mephentermine (group F), in addition to the use of a specific gradient elution (gradient F), the presence of the product ion at m/z 133 in the mass spectra of the precursor m/z 163 helps in the identification of the compound as mephentermine, as the product ion is not present in the mass spectra of the other two compounds (see
Figures 1 and 3).
Another possibility to identify isomeric compounds is the use of GC-MS analysis, without or with derivatization ( Table 3 ). In that case, the urine sample has to be subjected to an extraction procedure before the chromatographic analysis (see experimental section). Using GC-MS without derivatization, identification of different isomeric groups can be easily achieved because of the different retention times and also different electron ionization mass spectra (see groups C and E). The separation of the diastereomeric pairs norephedrine/norpseudoephedrine (group A) and ephedrine/pseudoephedrine (group B) can be accomplished by GC/MS using a very slow temperature program (ramp 1).
Using GC-MS as TFA-derivatives, some isomeric compounds can be also distinguished because of the different retention times and electron ionization mass spectra (see groups C, E and F) [33] .
The method developed, not being a chiral oriented analysis, does not separate the d-and l-enantiomers of amphetamine and metamphetamine. For these enantiomeric compounds (group C), a chiral separation, such as the diastereomeric derivatization with l-N-trifluoroacetyl-1-prolyl chloride [34] should be carried out.
CONCLUSIONS
A fast screening method based on UHPLC-MS/MS analysis was developed and validated for the simultaneous detection of 63 stimulants in urine at the concentration levels required by WADA. Neither extraction nor evaporation is required for processing the urine sample, which minimizes the loss of volatile analytes during the sample preparation.
The existence of isomeric stimulants with close retention times and/or similar ion transitions did not allow the unequivocal identification of these compounds in the initial testing procedure. Different possibilities for separation and identification of isomeric compounds were proposed, including the use of improved chromatographic gradients or the analysis by GC-MS without or with derivatization.
As a result of simple sample preparation and short LC-MS/MS analysis, a fast turn-around time is achieved. These features make the developed method highly interesting for routine anti-doping purposes. 
